A PHARMACEUTICAL COMPOSITION COMPRISING A PHARMACEUTICALLY EFFECTIVE AMOUNT OF AN INSULIN SENSITIZER AGENT AND A PHARMACEUTICALLY EFFECTIVE AMOUNT OF AN FB PASE INHIBITOR

摘要

Pharmaceutical compositions containing an FBPase Inhibitor and an insulin sensitizer are provided as well as methods for treating diabetes and diseases responding to increased glycemic control, an improvement in insulin sensitivity, a reduction in insulin levels, or an enhancement of insulin secretion.